Gin Hwa Biotech (ROCO:7806) FCF Margin %: -59.91% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7806 Gin Hwa Biotech Inc ROCO:7806
22 GF Score
Price NT$61.90
! 2 Warning Signs
View Full Analysis

What is Gin Hwa Biotech FCF Margin %?

Gin Hwa Biotech ROCO:7806 22 FCF Margin % is -59.91% as of Dec. 2025. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, Gin Hwa Biotech ranks better than 56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gin Hwa Biotech's Free Cash Flow for the six months ended in Dec. 2025 was NT$-152.5 Mil. Gin Hwa Biotech's Revenue for the six months ended in Dec. 2025 was NT$254.5 Mil. Therefore, Gin Hwa Biotech's FCF Margin % for the quarter that ended in Dec. 2025 was -59.91%.

As of today, Gin Hwa Biotech's current FCF Yield % is -13.73%.

The historical rank and industry rank for Gin Hwa Biotech's FCF Margin % or its related term are showing as below:

ROCO:7806' s FCF Margin % Range Over the Past 10 Years
Min: -43.96   Med: -27.61   Max: 57.29
Current: -43.96

During the past 4 years, the highest FCF Margin % of Gin Hwa Biotech was 57.29%. The lowest was -43.96%. And the median was -27.61%.

ROCO:7806's FCF Margin % is ranked better than
56% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:7806: -43.96

Gin Hwa Biotech FCF Margin % Related Terms

Gin Hwa Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Gin Hwa Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gin Hwa Biotech FCF Margin % Chart

Gin Hwa Biotech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
57.29 -43.67 -11.54 -43.96

Gin Hwa Biotech Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial -112.33 3.63 -25.80 -29.69 -59.91

ROCO:7806 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Gin Hwa Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gin Hwa Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gin Hwa Biotech's FCF Margin % falls into.


ROCO:7806
22GF Score
Gin Hwa Biotech Inc ROCO:7806
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gin Hwa Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gin Hwa Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-236.817/538.649
=-43.96 %

Gin Hwa Biotech's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-152.451/254.458
=-59.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -59.91% mean?
Gin Hwa Biotech (ROCO:7806) has a FCF Margin % of -59.91% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gin Hwa Biotech and its competitors. According to the industry distribution chart, Gin Hwa Biotech ranks #418 out of 950 companies in the Biotechnology industry, placing it in the top 44%.
Is Gin Hwa Biotech's FCF Margin % too high?
Gin Hwa Biotech's current FCF Margin % is -59.91%. Based on the distribution chart, Gin Hwa Biotech ranks #418 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #418 out of 950 companies for FCF Margin %. This puts Gin Hwa Biotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current FCF Margin % is -59.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current FCF Margin % of -59.91%. The current FCF Margin % is -59.91%. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current FCF Margin % is -59.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gin Hwa Biotech Business Description

Address No. 5, Guangming 7th Lane, Weixin Road, 1st Floor, Yong'an District, Kaohsiung, TWN, 828
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score

Get the complete analysis for ROCO:7806

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.90
Price